(Q71585954)

English

Induction of antitumor immunity and treatment of preestablished tumor by interleukin-6-gene-transfected melanoma cells combined with low-dose interleukin-2

scientific article published on 01 January 1995

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Induction of antitumor immunity and treatment of preestablished tumor by interleukin-6-gene-transfected melanoma cells combined with low-dose interleukin-2 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

X Cao

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

W Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

S Gu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Y Yu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Q Tao

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

T Ye

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 January 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

121

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

721-728

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

https://scigraph.springernature.com/pub.10.1007/bf01213318

0 references

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of recombinant interleukin 6 in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 in cancer treatment: disappointing or (still) promising? A review

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of tumor-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumor cells and recombinant interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-bearing animals contain suppressed antitumor effectors the function of which can be unmasked by IL-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biology of interleukin-6

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined therapy with IL-6 and inactivated tumor cells suppresses metastasis in mice bearing 3LL lung carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-2 induces IL-6 production in human monocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfection of transforming growth factor-beta producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effect of IL-2 and IL-6 on the lytic activity of purified human peripheral blood large granular lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-beta 2/interleukin 6 is a co-stimulant for human T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effect of locally produced and exogenous interleukin-6 on tumor growth in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-6 increases carcinoembryonic antigen and histocompatibility leukocyte antigen expression on the surface of human colorectal carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IFN-beta 2/IL-6 augments the activity of human natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7499443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01213318

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499443%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71585954&oldid=1755062254"